Ångström AI Analysis: $500K Raised
What is Ångström AI?
Ångström AI builds AI physics simulation tools for pharmaceutical research. The site says it replaces lab experiments with computation and targets properties such as solubility, lipophilicity, crystal stability, and binding behavior. Its published work claims experimental or subchemical accuracy while running orders of magnitude faster than traditional simulations.
Location
San Francisco, United States
Employees
1-10
Founded
2024
Product Features & Capabilities
- Accelerating molecular simulation, computing free energy differences, binding conformations, hydration sites, ab initio accuracy, efficient alchemical free energy method, machine learned potentials, pretrained MACE model, sub-chemical accuracy for hydration free energies, generative models for Boltzmann distribution, FAB method, equivariant generative model architecture, discrete normalizing flow, fast density evaluation.
How much Ångström AI raised
Seed - $500K
July 2024Lead Investor: Y Combinator
Who are the founders of Ångström AI
Business Model
Generative AI-based molecular simulations for drug development; revenue from partnerships and licensing.
Market Focus
Ångström AI primarily focuses on the molecular simulation industry, utilizing generative AI to enhance computational methods in this field.
Competitors Overview
Ångström AI operates in the molecular simulation and generative AI market, where it faces competition from several notable companies:
-
Noble.Ai: This company focuses on solving complex problems in chemicals, materials, and formulations using a data-efficient Science-Based AI platform. Noble.Ai's Reactor platform integrates machine learning with scientific principles, which may provide advantages in accelerating in-silico discovery compared to Ångström AI's offerings.
-
Zapata AI: While specific details about Zapata AI's offerings in molecular simulation were not found, it is known for its focus on quantum computing and AI applications in chemistry, which could provide unique advantages in simulating molecular interactions.
-
DataStax: Primarily known for its database solutions, DataStax has been involved in AI applications that can enhance data management in chemical simulations. However, specific advantages in molecular simulation were not detailed in the sources.
-
IBM Corporation: A major player in AI and chemical markets, IBM leverages its strong AI infrastructure and research capabilities, which may offer significant advantages in developing advanced molecular simulation technologies.
-
Google: Known for its extensive data resources and machine learning expertise, Google is also a competitor in the generative AI space, potentially providing robust solutions for molecular simulations.
-
Mitsui Chemicals: This company integrates AI with its chemical products, focusing on innovations in chemical manufacturing, which could provide competitive advantages in the market.
-
Accenture: As a consulting firm, Accenture integrates AI solutions across various industries, including chemicals, which may enhance its competitive position in the market.
These competitors vary in their technological capabilities, market focus, and partnerships, which can influence their effectiveness in the molecular simulation and generative AI sectors.
Investors
- Cleo Capital
- IA Seed Ventures
- JME Venture Capital
- Pioneer Fund
- Rebel Fund
- Y Combinator
See something that needs updating? Suggest edits to this profile.